(Q52167526)

26 April 2018

title

Effects of pacatal on symptoms in chronic psychotic female in-patients. (English)

1 reference

26 April 2018

1 reference

KING A

1

1 reference

26 April 2018

MITCHELL PH

series ordinal

2

1 reference

26 April 2018

SYKES P

series ordinal

3

1 reference

26 April 2018

language of work or name

English

0 references

publication date

1 January 1957

1 reference

26 April 2018

number of pages

4

1 reference

inferred from page(s)

published in

The BMJ

1 reference

26 April 2018

volume

1

1 reference

26 April 2018

issue

5012

1 reference

26 April 2018

page(s)

204-207

1 reference

26 April 2018

Complications of chlorpromazine therapy in 800 mental-hospital patients.

cites work

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974236

Use of pacatal (N-methylpiperidyl-(3)-methylphenothiazine) in psychiatric patients

13 August 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974236

Preliminary report on 500 patients treated with thorazine at Rochester State Hospital.

13 August 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974236

13 August 2018

1 reference

12 December 2020

[Lacumin therapy in severe mental disorders]

1 reference

12 December 2020

[Agranulocytosis after phenothiazine administration]

1 reference

12 December 2020

Chlorpromazine dermatitis in nurses

1 reference

12 December 2020

Chlorpromazine in the treatment of the chronic disturbed schizophrenic patient

1 reference

12 December 2020

[Pharmacological studies on N-alkyl-piperidyl-phenothiazine derivatives]

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.1.5012.204

1 reference

26 April 2018

PMCID

1974236

1 reference

26 April 2018

PubMed ID

13383230

1 reference

26 April 2018